BETR.CN
BetterLife Pharma Inc
Price:  
0.09 
CAD
Volume:  
60,920.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BETR.CN WACC - Weighted Average Cost of Capital

The WACC of BetterLife Pharma Inc (BETR.CN) is 7.8%.

The Cost of Equity of BetterLife Pharma Inc (BETR.CN) is 8.05%.
The Cost of Debt of BetterLife Pharma Inc (BETR.CN) is 5.00%.

Range Selected
Cost of equity 6.40% - 9.70% 8.05%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 9.3% 7.8%
WACC

BETR.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.64 0.9
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 9.70%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.07 0.07
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 9.3%
Selected WACC 7.8%